NLRP3 and Alzheimer disease: Findings from the preclinical study confirmed that miR-212-3p has a neuroprotective effect against the pathogenesis of AD by inhibiting the expression of NLRP3 inflammasome, attenuating the expression of β-secretase and reducing neuronal pyroptosis in AD rat model (Nong et al. 2022).